Xenetic Biosciences, Inc. (XBIO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$6.72M

Year ended 2022-12-31

2013-12-31 EBITDA (USD) 2022-12-31

Period ended	EBITDA	Change YoY	Source filing
2022-12-31	-$6.72M	n/m	2024-03-21, From 2022-01-01
2021-12-31	-$5.75M	n/m	2023-03-22, From 2021-01-01
2020-12-31	-$13.94M	n/a	2022-03-22, From 2020-01-01
No annual figure between 2015-12-31 and 2020-12-31.
2015-12-31	-$9.77M	n/m	2017-03-31, From 2015-01-01
2014-12-31	-$12.84M	n/m	2016-03-30, From 2014-01-01
2013-12-31	-$8.56M	n/a	2015-07-20, From 2013-01-01